Ambu A/S narrowed earnings guidance for the full-year 2022/23. For the year, the company expected organic revenue growth guidance to 6%-8%, previously 5%-8%; EBIT margin before special items: 5-6% (maintained as per 10 July 2023).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
119.6 DKK | -0.46% | +5.80% | +13.64% |
Apr. 12 | Nordic Stocks Rose Friday; BioArctic Series B Climbed Highest | DJ |
Apr. 11 | U.S. Futures Down, European Stocks Mixed | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.64% | 4.6B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- AMBU B Stock
- News Ambu A/S
- Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23